US Patent 9079908 Inhibitors of Bruton'S tyrosine kinase
Patent 9079908 was granted and assigned to Pharmacyclics on July, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+128 characters)
Article
Patent abstract
Described herein are irreversible kinase inhibitor compounds exemplified by the following structure Formula (B2):
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09079908 Inhibitors of Bruton'S tyrosine kinase US Patent 9079908 Inhibitors of Bruton'S tyrosine kinase
Infobox
Patent Number
09079908
Patent Number
9079908
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09079908 Inhibitors of Bruton'S tyrosine kinase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09079908
Date of patent
July 14, 2015
Patent application number
13543065
Date Filed
July 6, 2012
Patent primary examiner
Find more entities like US Patent 9079908 Inhibitors of Bruton'S tyrosine kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
